Ryder, R., Holman, R., & Gwilt, M. (2016). This house believes that sulphonylureas should not be used routinely as second-line treatments for patients with type 2 diabetes. Association of British Clinical Diabetologists.
Chicago-Zitierstil (17. Ausg.)Ryder, R., R. Holman, und M. Gwilt. This House Believes That Sulphonylureas Should Not Be Used Routinely as Second-line Treatments for Patients with Type 2 Diabetes. Association of British Clinical Diabetologists, 2016.
MLA-Zitierstil (9. Ausg.)Ryder, R., et al. This House Believes That Sulphonylureas Should Not Be Used Routinely as Second-line Treatments for Patients with Type 2 Diabetes. Association of British Clinical Diabetologists, 2016.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.